Finland· FI-REL-REL36257
Albunorm
A albumin product containing albumin, human, registered in Finland by Octapharma AB. The same ATC class is registered in 13 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Albumin is registered in 13 of 19 countries.
Countries holding a registration under ATC B05AA01 (albumin), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 8 of them publish a price we can compare per daily dose
Albumin · ATC B05AA01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Albumin, human
- Manufacturer
- Octapharma AB
- Country
- Finland (FI)
- ATC code
- B05AA01
- ATC class
- Albumin
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Albumin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandCrealb 40 g/lProthya Biosolutions Netherlands B.V.
- CzechiaALBUNORMOctapharma (IP) SPRL, Anderlecht
- United KingdomAlba 20% solution for infusion 100ml bottlesScottish National Blood Transfusion Service
- United StatesAlbukedKEDRION BIOPHARMA, INC.
- BelgiumAlbumine 20 %Centrale Afdeling Voor Fractionering - Departement Central De Fractionnement
- Japan人血清アルブミン日本血液製剤機構
- GermanyAlbiominBiotest Pharma Gmbh
- FranceALBUNORM 20 %, 200 g/l, solution pour perfusionOCTAPHARMA FRANCE
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Albiomin, Albunorm
- Belgium · Albunorm, Human Albumin Baxalta
- Bulgaria · Aлбунорм, Албиомин
- Cyprus · Albiomin, Albuman
- Czechia · Albunorm, Albutein
- Germany · Albiomin, Albunorm
- Denmark · Albumin Baxalta, Albumin Grifols
- Estonia · Albumin Baxalta, Albunorm
- Spain · Albiomin, Albuplan
- France · Albumine Humaine, Albunorm
- United Kingdom (Northern Ireland) · Albunorm, Albutein
- Greece · Albiomin, Albumine Lfb
- Croatia · Albutein, Flexbumin
- Hungary · Albumon, Albunorm
- Ireland · Albunorm, Albutein
- Iceland · Albuman, Albumin Baxalta
- Italy · Albiomin, Albital
- Lithuania · Albumin Baxalta, Albunorm
- Luxembourg · Albunorm, Human Albumin Baxalta
- Latvia · Albumin Baxalta, Albunorm
- Malta · Albiomin, Albunorm
- Netherlands · Albuman, Albunorm
- Norway · Albumin Baxalta, Albumin Grifols
- Poland · Albiomin, Albunorm
- Portugal · Albiomin, Albumina Humana Baxalta
- Romania · Albiomin, Albumină Umană Baxalta
- Sweden · Albumin Baxalta, Albumin Octapharma
- Slovenia · Albunorm, Flexbumin
- Slovakia · Albunorm, Albutein
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a8823e2a-a407-4fb0-b58b-bda67fdd7daa GET /v1/drugs/a8823e2a-a407-4fb0-b58b-bda67fdd7daa?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "infuusioneste, liuos",
"route": "Laskimoon",
"ddd_unit": null,
"strength": "40 g/l",
"atc_label": "albumiini",
"ma_number": "28105",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL36257",
"authorised_at": "2010-07-27"
}See everything about albumin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.